Takahashi Yuko, Sasamori Yukifumi, Higuchi Risa, Kaku Asumi, Kumagai Tomoo, Watanabe Saya, Nishizawa Miki, Takasaki Kazuki, Nishida Haruka, Ichinose Takayuki, Hirano Mana, Miyagawa Yuko, Hiraike Haruko, Kido Koichiro, Ishikawa Hirono, Nagasaka Kazunori
Department of Obstetrics and Gynecology, Teikyo University School of Medicine, Tokyo, Japan.
Graduate School of Public Health, Teikyo University, Tokyo, Japan.
PLoS One. 2025 Jan 7;20(1):e0311588. doi: 10.1371/journal.pone.0311588. eCollection 2025.
The incidence and mortality rates of cervical cancer are increasing among young Japanese women. In November 2021, the Japanese Ministry of Health, Labour, and Welfare reinstated the active recommendation of the human papillomavirus (HPV) vaccine, after it had been suspended in June 2013 due to reports of adverse reactions. However, vaccine hesitancy is prevalent in the younger generation in Japan. To identify obstacles to vaccine uptake, we conducted a randomized study using different methods to provide educational content to improve health literacy regarding cervical cancer and HPV vaccination among Japanese female students. We surveyed 188 Japanese female students, divided into three groups according to the intervention: no intervention, print-based intervention, and social networking service-based intervention. Twenty questionnaires and the Communicative and Critical Health Literacy scales were used as health literacy scales. Participants' knowledge and health literacy improved regardless of the method of education. In fact, participants acquired proper knowledge when given the opportunity to learn about the importance of the disease and its prevention. Therefore, medical professionals in Japan must provide accurate scientific knowledge regarding routine HPV vaccination and the risk of cervical cancer in young women to improve their health literacy and subsequently increase HPV vaccination rates in Japan, which may lead to cervical cancer elimination. Trial registration number: UMIN000036636.
日本年轻女性宫颈癌的发病率和死亡率正在上升。2021年11月,日本厚生劳动省恢复了对人乳头瘤病毒(HPV)疫苗的积极推荐,该疫苗曾因不良反应报告于2013年6月暂停使用。然而,疫苗犹豫在日本年轻一代中普遍存在。为了确定疫苗接种的障碍,我们进行了一项随机研究,采用不同方法提供教育内容,以提高日本女学生对宫颈癌和HPV疫苗接种的健康素养。我们调查了188名日本女学生,根据干预措施将她们分为三组:无干预组、基于印刷品的干预组和基于社交网络服务的干预组。使用20份问卷和沟通与批判性健康素养量表作为健康素养量表。无论教育方法如何,参与者的知识和健康素养都有所提高。事实上,当有机会了解疾病的重要性及其预防措施时,参与者获得了正确的知识。因此,日本的医学专业人员必须提供关于常规HPV疫苗接种和年轻女性宫颈癌风险的准确科学知识,以提高她们的健康素养,并随后提高日本的HPV疫苗接种率,这可能会导致消除宫颈癌。试验注册号:UMIN000036636。